First County Bank CT grew its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 581.1% during the third quarter, Holdings Channel.com reports. The firm owned 10,604 shares of the conglomerate’s stock after buying an additional 9,047 shares during the period. Danaher comprises about 1.0% of First County Bank CT’s portfolio, making the stock its 23rd biggest holding. First County Bank CT’s holdings in Danaher were worth $2,349,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in DHR. BlackRock Inc. acquired a new stake in shares of Danaher during the second quarter worth approximately $10,492,520,000. Jupiter Topco LLC purchased a new position in Danaher during the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in Danaher in the 2nd quarter valued at approximately $1,287,949,000. Bank of America Corp DE acquired a new position in Danaher in the 2nd quarter valued at approximately $993,846,000. Finally, Legal & General Group Plc purchased a new stake in Danaher in the 2nd quarter worth approximately $801,056,000. 79.05% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
DHR has been the subject of a number of research reports. The Goldman Sachs Group lifted their target price on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Guggenheim boosted their price target on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. TD Cowen upped their price target on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $235.41.
Danaher Stock Performance
Danaher stock traded up $2.92 during trading hours on Tuesday, reaching $224.12. 2,440,239 shares of the company were exchanged, compared to its average volume of 4,441,847. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a 50-day moving average of $211.85 and a 200 day moving average of $194.88. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The firm has a market cap of $157.55 billion, a price-to-earnings ratio of 39.82, a PEG ratio of 2.74 and a beta of 0.76.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the business posted $0.77 EPS. The company’s revenue for the quarter was up 5.5% on a year-over-year basis. As a group, research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.
Danaher Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio is presently 28.42%.
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.
Further Reading
- Five stocks we like better than Danaher
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
- JPMorgan Earnings Miss Estimates But Reveal Broad-Based Strength
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
